Cyclodextrin‐Catalyzed Deacetylation of Spironolactone is pH and Cyclodextrin Dependent
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 89 (2) , 241-249
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Improved bioavailability and clinical response in patients with chronic liver disease following the administration of a spironolactone: β‐cyclodextrin complexBritish Journal of Clinical Pharmacology, 1997
- Effect of Alkyl Chain Length and Degree of Substitution on the Complexation of Sulfoalkyl Ether β-Cyclodextrins with SteroidsJournal of Pharmaceutical Sciences, 1997
- Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug DeliveryJournal of Pharmaceutical Sciences, 1996
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996
- Effect of 2-hydroxypropyl-β-cyclodextrin on the stability of prostaglandin E2 in solutionInternational Journal of Pharmaceutics, 1994
- Preformulation Studies of Spironolactone: Effect of pH, Two Buffer Species, Ionic Strength, and Temperature on StabilityJournal of Pharmaceutical Sciences, 1991
- Cyclodextrin-accelerated degradation of β-lactam antibiotics in aqueous solutionsInternational Journal of Pharmaceutics, 1991
- Physical properties and dissolution profiles of tablets directly compressed with β-cyclodextrinInternational Journal of Pharmaceutics, 1990
- Enhancement of oral bioavailability of spironolactone by .BETA.- and .GAMMA.-cyclodextrin complexations.Chemical and Pharmaceutical Bulletin, 1983
- Cyclodextrin inclusion catalysis in the isomerization of prostglandin A1.Chemical and Pharmaceutical Bulletin, 1979